BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 11, 2009
View Archived Issues
EMD-121974 combined with chemoradiotherapy may improve survival in cancer patients
Read More
Subretinal gene delivery of adeno-viral RPE65 is safe and effective in retinal degeneration patients
Read More
University of Maryland and Mitsubishi Tanabe Pharma claim KAT II inhibitors for AD
Read More
Boehringer Ingelheim discloses cannabinoid CB2 receptor agonists as analgesics
Read More
New Parkinson's disease clinical trial results reported at Movement Disorder Society meeting
Read More
HIV reverse transcriptase inhibitors in early development at Merck & Co.
Read More
Bayer Schering Pharma patents describe novel prostanoid IP receptor agonists
Read More
Novartis discloses CSF-1R inhibitors for the treatment of cancer
Read More
Efficacy and favorable safety of CCX282-B shown in induction of response phase of PROTECT-1 trial
Read More
BioMarin reports results from phase I PEG-PAL in phenylketonuria
Read More
Talecris receives orphan drug designation for human plasmin
Read More
ViroMed completes dosing in phase I trial for VM-202 in cardiovascular disease
Read More
FDA issues 74-day letter with respect to SkyePharma's NDA for asthma drug Flutiform
Read More
CHMP recommends granting of marketing authorization for Orphan Europe's Vedrop
Read More
FDA cleares Morphotek's IND to study MORAb-004 in solid tumors
Read More
Amarin reports results from phase IIa EN-101 trial in myasthenia gravis
Read More
FDA accepts for filing MonoSol's NDA for ondansetron orally dissolving film strip
Read More
Genmab completes recruitment in zalutumumab head and neck cancer study
Read More
GenPhar prepares tetravalent dengue vaccine for phase I clinical trials
Read More
Kamada reports positive proof-of-concept data for inhaled alpha-1 antitrypsin
Read More
NeurogesX provides FDA regulatory update for Qutenza
Read More
Delcath enrolls 75% of subjects in phase III clinical trial of PHP in melanoma
Read More
Istradefylline reduces off time in Parkinson's disease patients with motor complications
Read More
AS-1907417 shows preclinical potential for the treatment of type 2 diabetes
Read More
CIS-565C improves glucose metabolism with fewer CNS side effects in mouse models of obesity
Read More
Bayhill and Genentech sign worldwide license agreement for BHT-3021 in type 1 diabetes
Read More
Collegium submits SPA to FDA for phase III pivotal trial of tamper-resistant opioid COL-003
Read More